Back
Coca-Cola Femsa SAB de CV Vs. Corcept Therapeutics Industry Stock Comparison
Buy
61
COCSF
Coca-Cola Femsa SAB de CV
Last Price:
9.7000
Seasonality Move:
-1.22%
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
61
Coca-Cola Femsa SAB de CV (COCSF)
is a Buy
Is Coca-Cola Femsa SAB de CV a Buy, Sell or Hold?
- The current Coca-Cola Femsa SAB de CV [COCSF] share price is $9.7000. The Score for COCSF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- COCSF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COCSF Stock Price Chart
What is Coca-Cola Femsa SAB de CV's stock price today?
-
The Coca-Cola Femsa SAB de CV share price today is $9.7000
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COCSF is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
COCSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62.23 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.4111 - 9.1311) | Buy |
Bollinger Bands (100): | (8.4292 - 9.5292) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 72.34 | Buy |
Chaikin Money Flow: | -986948 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
COCSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.66 | Buy |
20-day SMA: | 8.73 | Buy |
50-day SMA: | 8.83 | Buy |
200-day SMA: | 9.2 | Buy |
8-day EMA: | 8.87 | Buy |
20-day EMA: | 8.77 | Buy |
50-day EMA: | 8.81 | Buy |
200-day EMA: | 8.9 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.22 | Buy |
20-day SMA: | 36.07 | Buy |
50-day SMA: | 35.08 | Buy |
200-day SMA: | 28.51 | Buy |
8-day EMA: | 38.83 | Buy |
20-day EMA: | 36.86 | Buy |
50-day EMA: | 34.93 | Buy |
200-day EMA: | 30.16 | Buy |
Coca-Cola Femsa SAB de CV Earnings Growth & COCSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Coca-Cola Femsa SAB de CV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |